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Edited by Stuart FergusonAbstract Gramicidin S, a cationic cyclic decapeptide, exhibits
the potent antibiotic activity through perturbation of lipid bilay-
ers of the bacterial membrane. From the screening of natural
antibiotics, we identiﬁed gramicidin S as a potent inhibitor for
cytochrome bd-type quinol oxidase from Escherichia coli. We
found that gramicidin S inhibited the oxidase with IC50 of
3.5 lM by decreasing Vmax and the aﬃnity for substrates but
showed the stimulatory eﬀect at low concentrations. Our ﬁndings
would provide a new insight into the development of gramicidin S
analogs, which do not share the target and mechanism with con-
ventional antibiotics.
 2008 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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The emergence of antibiotic-resistant strains of major path-
ogenic bacteria such as Staphylococcus aureus is an increas-
ingly serious public health concern [1]. To evade bacterial
drug resistance mechanisms, new eﬀective chemotherapeutic
agents, which have novel mechanisms of action as well as dif-
ferent cellular targets compared with conventional antibiotics,
need to be developed [2].
Short cationic amphiphilic peptides form part of the biolog-
ical defense system of a broad range of organisms [3]. Cationic
amphiphilic peptides are used by microorganisms to suppress
the growth of competitors in the same nitche and are part of
innate immune defenses of higher organisms. Membrane lipid
bilayer rather than cellular proteins was considered their pri-
mary target. It should be noted that, in mammals, many host
defense peptides have additional chemokine-like and immuno-
modulatory activities [3,4]. Unlike conventional antibiotics,
acquisition of resistance against antimicrobial peptides is sur-
prisingly improbable. Naturally occurring cationic amphiphilic
peptides retained the antimicrobial activity for millions of
years and may represent a new generation of promising
broad-spectrum antibiotics for combat against the rapidly
growing numbers of antibiotic-resistant microorganisms.*Corresponding author. Fax: +81 3 5841 3444.
E-mail address: tmogi@m.u-tokyo.ac.jp (T. Mogi).
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doi:10.1016/j.febslet.2008.05.031Soil bacterium Aneurinibacillus migulanus (formerly known
as Bacillus brevis) secretes antibiotics tyrothricin, a mixture
of linear pentadecapeptides (gramicidin A, B and C) and back-
bone cyclized decapeptides (gramicidin S (GS1) and tyrocidins)
[5,6]. GS is a cationic cyclic decapeptide with the primary
structure [cyclo-(Val-Orn-Leu-D-Phe-Pro)2] and has an anti-
parallel b-sheet structure supported by two type II 0 b-turns
[5–7]. GS molecule is amphiphilic, with two charged Orn side
chains and two D-Phe rings projecting from one side of the
molecule and four hydrophobic Val and Leu side chains pro-
jecting from the other. GS is an extremely powerful antibiotic
drug against a broad spectrum of both Gram-negative and
Gram-positive bacteria and against several pathogenic fungi
with the minimum inhibitory concentration of 3–11 lM [8,9].
Although the mechanism of antibacterial activity of GS is
not completely established, the primary mode of action is gen-
erally assumed to perturb lipid packing, resulting in destruc-
tion of the membrane integrity and enhancement of the
permeability of the lipid bilayer of the bacterial cytoplasmic
membrane [10,11]. Upon partitioning into lipid bilayers GS
would displace lipid molecules in a leaﬂet, then the accumula-
tion of signiﬁcant amounts of GS in any membrane is incom-
patible with the maintenance of a stable bilayer structure [12].
Unfortunately, GS is very hemolytic, thus restricting the use of
GS to topical applications at present [5,6]. Recently, tyrocidin
A was shown to be a potent antiplasmodial agent for the hu-
man malaria parasite [13]. The 50% inhibitory concentration
(IC50) for bloodstream forms was only 0.6 nM, indicating the
presence of a speciﬁc molecular target.
Cytochrome bd-type quinol oxidase is a widely distributed
bacterial terminal oxidase, and performs a variety of physio-
logical functions such as the microaerophilic respiration and
protection against oxygen stress [14,15]. Cytochrome bd also
plays an important role in survival and adaptation of patho-
genic bacteria that encounter host environments in which diox-
ygen is progressively limited [16–18]. Since cytochrome bd is
totally absent in eukaryotic mitochondria, such alternative
respiratory enzymes are promising targets for new chemother-
apeutics.
Here we report for the ﬁrst time that GS is a potent inhibitor
for cytochrome bd-type quinol oxidase. From the screening of
hundreds of natural antibiotics in the Kitasato Institute for
Life Sciences Chemical Library [19], we found the inhibitory
activity of GS for Escherichia coli cytochrome bd. Recent stud-
ies have shown that GS analogs can be designed with the
markedly improved therapeutic index, suggesting the possibil-
ity of GS derivatives as potent broad-spectrum antibioticsblished by Elsevier B.V. All rights reserved.
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ular design and development of new GS analogs.Fig. 1. Eﬀects of GS on ubiquinol-1 oxidase activity of cytochrome bd.
Reactions were initiated by addition of ubiquinol-1 at a ﬁnal
concentration of 100 lM after 2-min preincubation of the E. coli
membranes with GS (d) or immediately after mixing with GS (s).
Dose–response curves were ﬁtted by using the equation for the relative
enzyme activity, v = 1  i/(1 + IC50/[GS]) + e/(1 + EC50/[GS]n), where i
and e are the initial amplitudes of the inhibitory and stimulatory
component, respectively, IC50 and EC50 denote the 50% inhibitory and
stimulatory concentration, respectively, of the ligand, and n is the Hill
coeﬃcient [26]. Parameters for 2-min preincubation consisted of an
inhibitory component with IC50 = 2.61 ± 0.34 lM and i = 1.14 ± 0.05
and a stimulatory component with EC50 = 0.05 ± 0.07 lM and e =
0.12 ± 0.06. Parameters for without preincubation consisted of an
inhibitory component with IC50 = 17.4 ± 3.3 lM and i = 1.57 ± 0.07
and a stimulatory component with EC50 = 0.17 ± 0.02 lM, e = 0.52 ±
0.05 and n = 2.6. Relative activity 1.0 corresponds to 1440 ubiquinol-
1/enzyme/s in the presence of 1% ethanol.2. Materials and methods
2.1. Preparation of membranes and puriﬁcation of enzymes
Cytoplasmic membrane vesicles were isolated from E. coli ST4683/
pNG2 (Dcyo Dcyd/cyd+ TetR) and GO103/pMFO2 (cyo+ Dcyd/cyo+
AmpR), which overproduce cytochrome bd and bo, respectively, as
the sole terminal oxidase [23,24]. Cytochrome bd, cytochrome bo and
Complex II were puriﬁed as in [23,24].
2.2. Quinol oxidase assay
The enzyme activity was determined at 25 C with V-660 double
monochromatic spectrophotometer (JASCO, Tokyo, Japan). The stan-
dard reaction mixture (1 ml) contained 50 mM potassium phosphate
(pH 6.5), 0.02% Tween 20 (Calbiochem), membranes, and GS (labora-
tory stock at the Kitasato Institute or a kind gift from Meiji Seika
Kaisha Ltd. (Tokyo, Japan)). Enzyme activities of intact membranes
and puriﬁed enzymes were determined in 50 mM Tris–HCl (pH 7.4)
containing 0.02% Tween 20, respectively. Reactions were started by
addition of substrates in the absence (for oxidases) or presence of
2 mM KCN (for NDH-II and Complex II). Substrates used are
100 lM ubiquinol-1 for oxidases, 200 lM NADH + 100 lM ubiqui-
none-1 for NDH-II, and 10 mM sodium succinate + 100 lM ubiqui-
none-1 for Complex II. Enzyme kinetics was analyzed as described
[23].
2.3. Dose–response analysis
Duplicate assays were performed at each concentration, and dose–
response data were analyzed by the non-linear regression curve-ﬁtting
with KaleidaGraph 4.0 (Synergy Software). IC50 values were estimated
as in [25]. For the analysis of the biphasic data, a model for the inter-
action of a ligand with two binding sites, one stimulatory and one
inhibitory [26], was used.
2.4. Growth assay
Isogenic E. coli strains, ST4785 (Dcyo cyd+; a P1 transductant of
ST4683) and GO103 (cyo+ Dcyd; a parental strain of ST4683) were
grown at 37 C in 1 ml of LB medium in multidish 48 wells (Nunc)
and the turbidity at 600 nm were measured after 12 h culture. IC50
was calculated from the growth yield of four independent culture.3. Results and discussion
3.1. Inhibition of bacterial bd-type quinol oxidase by GS
In the course of the screening for inhibitors of E. coli bd-type
quinol oxidase (CydAB), we identiﬁed GS as one of antibiotics
that showed the inhibitory activity (84% inhibition at 5 lg/ml)
greater than that of antimycin A (50%), a non-competitive
inhibitor for cytochrome bd [14,15]. In contrast, gramicidin
D, a-helical pentadecapeptides that form dimeric cationic
channels, did not show the inhibitory activity. We found that
cyanide-insensitive quinol oxidase (CioAB), a variant of cyto-
chrome bd lacking heme d, from Gluconobacter oxydans was
one-order of magnitude insensitive to GS.
3.2. Dose–response curves for inhibition of cytochrome bd by GS
In the presence of 0.02% Tween 20, eﬀects of GS on ubiqui-
nol-1 oxidase activity of the cytochrome bd-overproduced
membranes were examined with or without 2-min preincuba-
tion of the membranes with GS. Dose–response curve for
experiments without preincubation was biphasic (‘‘semi-bell-
shaped’’), with stimulation at 1 lM (Fig. 1). Upon mixing
with GS, the enzyme activity decreased monophasically atboth 0.5 (t1/2 = 151 ± 12 s) and 10 lM (t1/2 = 32 ± 3 s). IC50
for GS from two independent preparations was determined
to be 3.5 ± 0.4 and 17.6 ± 0.2 lM for with and without prein-
cubation, respectively. IC50 for GS was comparable to IC50 for
2-heptyl-4-hydroxyquinoline N-oxide (1 lM), antimycin A
(5 lM), and piericidin A (10 lM), inhibitors for the quinol oxi-
dation site present at the periplasmic surface of subunit I [23].
IC50 for cytochrome bd was also comparable to the minimum
inhibitory concentration of E. coli cells (3.5–16.7 lM) [9]. Our
ﬁndings indicate that besides disruption of the integrity of
cytoplasmic membrane GS could directly suppress the activi-
ties of energy transduction systems.
3.3. Kinetic analysis of inhibition of cytochrome bd by GS
In the presence of 0.02% Tween 20, kinetic analysis of eﬀects
of GS on the ubiquinol-1 oxidation was carried out. Sigmoidal
dose–response curves were analyzed based on the modiﬁed
ping-pong bi-bi mechanism [23]. Because of improvements in
assay conditions, apparent Km and Vmax values were changed
to 42 lM and 2370 ubiquinol-1/enzyme/s, respectively, in
50 mM potassium phosphate (pH 6.5)–0.02% Tween 20 (Fig.
2) from 123 lM and 464 ubiquinol-1/enzyme/s, respectively,
in 50 mM sodium phosphate (pH 7.4)–0.1% sucrose monolau-
rate [23]. Stimulation by GS at 0.5 lM can be attributed to the
60% increase in the apparent Vmax, associated with a slight de-
crease in the aﬃnity for ubiquinol-1 (56 lM). Inhibition by GS
at higher concentrations upon preincubation was mixed-type
and decreased the apparent Vmax and the binding aﬃnity for
substrates. We found that GS did not aﬀect spectroscopic
Fig. 2. Eﬀects of GS on kinetic parameters for the ubiquinol-1
oxidation by cytochrome bd. Kinetic analysis was carried out in the
absence of GS (d), after 2-min preincubation with 7.5 (,) or 15 lM
GS (m), and after without preincubation with 0.5 lM GS (s).
Sigmoidal enzyme kinetics was analyzed by using the equation
v = (Vmax * S * S)/(S * S + S * Km + Km * Km) [23]. Apparent Km and
Vmax (ubiquinol-1/enzyme/s) values obtained are 42 ± 2 lM and
2370 ± 44 s1 (control), 72 ± 5 lM and 1620 ± 52 s1 (7.5 lM GS
with preincubation), and 88 ± 7 lM and 1027 ± 55 s1 (15 lM GS
with preincubation), and 56 ± 4 lM and 3,807 ± 135 s1 (0.5 lM GS
without preincubation), respectively.
Fig. 3. Eﬀects of GS on the E. coli respiratory enzymes within intact
membranes and in detergent micelles. IC50 values were estimated as in
[25] using the equation: 1/(1 + ([GS]/IC50)
n) where n is the Hill
coeﬃcient. Eﬀects on cytochrome bd (m) was examined with ST4683/
pNG2 membranes and those on cytochrome bo (d), NDH-II (s) and
Complex II (n) were examined with GO103/pMFO2 membranes
where the expression of Complex I was negligibly low (deamino-
NADH:ubiquinone-1 reductase activity was only 0.5% of NADH:ubi-
quinone-1 reductase). (A) Cytoplasmic membranes in the absence of
detergents. IC50 values were estimated to be 5.4 ± 0.4 lM (n =
1.8 ± 0.2) for bd-type quinol oxidase, 45.4 ± 4.3 lM (n = 1.6 ± 0.2)
for bo-type quinol oxidase, 40.9 ± 1.9 lM (n = 1.9 ± 0.2) for NDH-II,
and >100 lM for Complex II. (B) Puriﬁed enzymes in detergent
micelles. IC50 values were estimated to be 5.3 ± 0.7 lM (n =
0.96 ± 0.12) for bd-type quinol oxidase, 189 ± 24 lM (n =
0.70 ± 0.06) for bo-type quinol oxidase, and >100 lM for Complex II.
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direction of changes in kinetic parameters by GS was opposite
to that of the activation of the enzyme activity by 0.02% Tween
20 in the reaction mixture. In case of membrane-bound Ca2+-
ATPases, GS inhibits sarcolemmal Ca2+-ATPase by uncom-
petitively and sarcolemmal Ca2+/Mg2+-ATPase and sarcoplas-
mic reticulum Ca2+-ATPase by mixed-type mechanism [27].
GS has been postulated to perturb interactions of mem-
brane-bound enzymes with boundary lipids [28], so eﬀects of
GS on membrane-bound enzymes could be alteration of pro-
tein structures through binding to their hydrophobic protein
surfaces.
3.4. Eﬀects of GS on E. coli respiratory enzymes in intact
membranes and in detergent micelles
We examined further eﬀects of GS on the E. coli respiratory
enzymes (bd- and bo-type quinol oxidases, NDH-II (a single-
subunit peripheral NADH dehydrogenase), and Complex II
(succinate dehydrogenase complex)) within intact membranes
and on puriﬁed enzymes in detergent micelles (Fig. 3). Cyto-
chrome bo-type quinol oxidase and NDH-II were 10-fold
insensitive to GS and Complex II was totally insensitive to
GS. Notably, upon puriﬁcation the Hill coeﬃcients for bd-
and bo-type quinol oxidases reduced to one-half from 1.8 to
0.96 and from 1.6 to 0.70, respectively, indicating the dimeric
organization of oxidases within membranes or the higher
accessibility to the GS-binding site(s) in membrane-bound
forms. Since IC50 values for membrane-bound and puriﬁed
cytochrome bd (5.4 and 5.3 lM, respectively) (Fig. 3) were
comparable to the minimum inhibitory concentration (MIC)
of E. coli cells (3.5–16.7 lM) [9], we determined IC50 for the
aerobic growth of the cytochrome bd-expressing and cyto-
chrome bo-expressing E. coli strains. However, the diﬀerence
in IC50 values for the growth (8.9 ± 0.3 and 8.8 ± 0.3 lM,
respectively; MIC = 20 lM in both strains) was insigniﬁcantprobably due to the presence of unidentiﬁed target(s) or break
down of lipid bilayer structure [12].
In conclusion, we report for the ﬁrst time that the E. coli bd-
type quinol oxidase is one of bacterial membrane targets for
GS (Fig. 4) although it is generally assumed that the principal
target of GS is the membrane lipid bilayer rather than the pro-
tein components. Recent studies have shown that structural
analogs of GS can be designed with markedly reduced hemo-
lytic activity and enhanced microbial activity, suggesting the
possibility of GS derivatives as potent oral or injectable
broad-spectrum antibiotics [9,20–22]. Our ﬁnding would pro-
vide a new insight into the molecular design and development
of novel GS-based antibiotics (see Fig. 4).
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